1.34
0.04 (3.08%)
0.04 (3.08%)
Upgrade to Real-Time
Premarket
Low
0.4222
High
2.32
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Regulus Therapeutics Inc | RGLS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.04 | 3.08% | 1.34 | 04:37:03 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.30 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 1.20 | 1.47 | 0.27 | - | - |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 2 | 200 | 2,396,433 | 0.4222 - 2.32 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 04:37:03 | formt | 171 | $ 1.34 | USD |
Regulus Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 89.65M | 66.90M | 63.38M | $ 6.83M | $ - | -1.09 | -1.70 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Regulus Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RGLS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.37 | 1.38 | 1.14 | 1.25 | 1,061,644 | -0.03 | -2.19% |
| 1 Month | 1.51 | 1.63 | 1.14 | 1.38 | 1,142,873 | -0.17 | -11.26% |
| 3 Months | 1.37 | 2.32 | 1.00 | 1.71 | 3,224,722 | -0.03 | -2.19% |
| 6 Months | 0.5401 | 2.32 | 0.45 | 1.47 | 2,466,727 | 0.7999 | 148.1% |
| 1 Year | 0.4616 | 2.32 | 0.4222 | 1.20 | 2,032,354 | 0.8784 | 190.29% |
| 3 Years | 7.8408 | 9.4848 | 0.4005 | 1.55 | 951,349 | -6.50 | -82.91% |
| 5 Years | 78.60 | 79.92 | 0.4005 | 8.81 | 859,114 | -77.26 | -98.3% |
Regulus Therapeutics Description
| Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. MicroRNA is a noncoding ribonucleic acid that regulates most genes in the genome. The company partnered with Sanofi to create a compound targeting orphan diseases and with AstraZeneca to cure Type 2 Diabetes/prediabetes. |
